[1]Patent:WO2016/29146,2016,A1.Locationinpatent:Paragraph0151
Title: Desipramine potentiation of the acute depressant effects of ethanol: modulation by alpha2-adrenoreceptors and stress.
Journal: Neuropharmacology 20081001
114872-98-9
14091-11-3
14173-40-1
80126-50-7
52031-05-7
111119-36-9
728894-87-9 | 4-(3-Methyl-1,2,4-oxadiazol-5-yl)benzonitrile | AA00IC93 | MFCD28369607
74051-80-2 | 2-[1-(ethoxyamino)butylidene]-5-(2-ethylsulfanylpropyl)cyclohexane-1,3-dione | AA00ICE0 | MFCD03792698
749920-71-6 | 4-methyl-3-(morpholine-4-carbonyl)-5-phenylthiophen-2-amine | AA00ICID | MFCD06337036
76813-80-4 | 2-Benzyloxybenzylamine hydrochloride | AA00ICOU | MFCD11520394
79016-59-4 | 1,2,3,4-Tetrahydropyrazino[2,1-a]isoindol-6(10bh)-one | AA00ICWS | MFCD12198737
80681-45-4 | Prim-o-glucosylcimifugin | AA00ID1V | MFCD09037394
82652-17-3 | Ethanone, 1-(4-fluorophenyl)-2-(methylsulfonyl)- | AA00ID6D | MFCD00202594
848179-08-8 | 3-amino-N,N,4,5-tetramethylbenzenesulfonamide | AA00IDDI | MFCD07324910
852851-85-5 | 4-Chloro-2-(piperidin-1-ylcarbonyl)pyridine | AA00IDJL | MFCD06655679
859232-71-6 | 4-Bromo-2-(methoxycarbonylmethyl)benzenesulfonamide | AA00IDQX | MFCD25967952